Publication Detail
The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Markers of Alzheimer's disease in a population attending a memory clinic.
Giovanni B Frisoni; Annapaola Prestia; Orazio Zanetti; Samantha Galluzzi; Melissa Romano; Maria Cotelli; Massimo Gennarelli; Giuliano Binetti; Luisella Bocchio; Barbara Paghera; et al. (Profiled Author: Frisoni, Giovanni B)
Laboratory of Epidemiology Neuroimaging and Telemedicine, IRCCS Centro San Giovanni di Dio FBF, Brescia, Italy. gfrisoni@fatebenefratelli.it
Alzheimer's & dementia : the journal of the Alzheimer's Association 2009;5(4):307-17.
BACKGROUND: New marker-based criteria for the diagnosis of Alzheimer's disease (AD) were recently proposed. We describe their operational translation in 144 consecutive patients referred to our Memory Clinic. METHODS: Visual ratings of hippocampal atrophy and of cortical glucose hypometabolism in magnetic resonance imaging and positron emission tomography, and concentrations of total tau and Abeta1-42 in cerebrospinal fluid were assessed in 12 patients with subjective memory complaints (SMCs) (Mini-Mental State Examination [MMSE] score, 28.0 +/- 1.1 [mean +/- SD]), 37 with mild cognitive impairment (MCI) (MMSE, 25.1 +/- 3.6), 55 with AD (MMSE, 21.1 +/- 3.5), and 40 with non-AD dementia (MMSE, 21.6 +/- 5.5). RESULTS: The sensitivity for AD of each individual biomarker was higher (65% to 87%) than for MCI (18% to 50%). Each biomarker's specificity for SMC and non-AD dementias was good to moderate (83% and 53%). Positivity for at least one marker increased the probability 38 times of belonging to the AD group (P < 0.0001). CONCLUSION: The new diagnostic criteria can be operationalized in clinical routines, but longitudinal studies of MCI patients will need to assess the criteria's prognostic value.
Scientific Context
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Related Grants
-
1.
PRICE, DONALD L
NEUROBIOLOGICAL STUDIES/ALZHEIMER'S/PARKINSON'S DISEASE
1 June 1982 - 31 August 1990
NATIONAL INSTITUTE ON AGING
Total Funding: $ 1,064,558
-
2.
Small, Gary W
FUNCTIONAL MRI FOR EARLY DIAGNOSIS OF ALZHEIMER'S
10 August 1995 - 31 August 2006
NATIONAL INSTITUTE ON AGING
Total Funding: $ 3,111,865
-
3.
MAYEUX, RICHARD
Epidemiology of Biomarkers of Risk and Progression in LOAD
1 May 2010 - 30 April 2015
NATIONAL INSTITUTE ON AGING
Total Funding: $ 5,932,714
Related Publications
-
1.
2010S M Landau; D Harvey; C M Madison; E M Reiman; N L Foster; P S Aisen; R C Petersen; L M Shaw; J Q Trojanowski; C R Jack; et al.
Comparing predictors of conversion and decline in mild cognitive impairment.
Neurology 2010;75(3):230-8. -
2.
2009P Vemuri; H J Wiste; S D Weigand; L M Shaw; J Q Trojanowski; M W Weiner; D S Knopman; R C Petersen; C R Jack;
MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change.
Neurology 2009;73(4):294-301. -
3.
2010M Lorenzi; M Donohue; D Paternicò; C Scarpazza; S Ostrowitzki; O Blin; E Irving; G B Frisoni;
Neurobiology of aging 2010;31(8):1443-51, 1451.e1.

Appears in this Publication








